Study: Symptom Resolution After Complications from Transvaginal Mesh

//Study: Symptom Resolution After Complications from Transvaginal Mesh

Study: Symptom Resolution After Complications from Transvaginal Mesh

Prolene Mesh

Prolene Mesh

This research published in January is available for purchase for $59 from the publication.  Note the numbers of complications for mesh exposure, pain and dyspareunia.

 

Symptom Resolution After Operative Management of Complications From Transvaginal Mesh

Crosby, Erin C. MD; Abernethy, Melinda MD, MPH; Berger, Mitchell B. MD, PhD; DeLancey, John O. MD; Fenner, Dee E. MD; Morgan, Daniel M. MD

Obstetrics & Gynecology

January 2014

Vol. 123 – Issue 1: p 134–139

http://journals.lww.com/greenjournal/toc/2014/01000

OBJECTIVE: Complications from transvaginal mesh placed for prolapse often require operative management. The aim of this study is to describe the outcomes of vaginal mesh removal.

METHODS: A retrospective review of all patients having surgery by the urogynecology group in the department of obstetrics and gynecology at our institution for a complication of transvaginal mesh placed for prolapse was performed. Demographics, presenting symptoms, surgical procedures, and postoperative symptoms were abstracted. Comparative statistics were performed using the χ2 or Fisher’s exact test with significance at P<.05.

RESULTS: Between January 2008 and April 2012, 90 patients had surgery for complications related to vaginal mesh and 84 had follow-up data. The most common presenting signs and symptoms were: mesh exposure, 62% (n=56); pain, 64% (n=58); and dyspareunia, 48% (n=43). During operative management, mesh erosion was encountered unexpectedly in a second area of the vagina in 5% (n=4), in the bladder in 1% (n=1), and in the bowel in 2% (n=2). After vaginal mesh removal, 51% (n=43) had resolution of all presenting symptoms. Mesh exposure was treated successfully in 95% of patients, whereas pain was only successfully treated in 51% of patients.

CONCLUSION: Removal of vaginal mesh is helpful in relieving symptoms of presentation. Patients can be reassured that exposed mesh can almost always be successfully managed surgically, but pain and dyspareunia are only resolved completely in half of patients.

LEVEL OF EVIDENCE: III

Michigan Pelvic Floor Research Group

http://obgyn.med.umich.edu/research/programs-units/pfrg/team

 

 

By | 2014-02-27T18:11:50+00:00 February 27th, 2014|Medical News|0 Comments

About the Author:

I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.

Leave A Comment